COMMUNIQUÉS West-GlobeNewswire

Adaptimmune to Report First Quarter 2018 Financial Results and Business Update on Wednesday May 9, 2018
25/04/2018
PHILADELPHIA and OXFORD, U.K., April 25, 2018 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq: ADAP ), a leader in T-cell therapy to treat cancer, will announce financial results for the First Quarter 2018 and [...]
PolarityTE, Inc. Regains Compliance With NASDAQ Independent Director Requirement
25/04/2018
SALT LAKE CITY, April 25, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq: COOL ) today announced it has received formal notification from the Listing Qualifications Department of The NASDAQ Stock Market ("NASDAQ") [...]
Chembio Diagnostics and LumiraDx Enter Collaboration to Develop New Point-of-Care Diagnostic Tests for Infectious Diseases
25/04/2018
MEDFORD, N.Y., April 25, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI ), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that it has entered into a [...]
Immune Design to Report First Quarter 2018 Financial Results and Provide Corporate Update
25/04/2018
SEATTLE and SOUTH SAN FRANCISCO, Calif., April 25, 2018 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq: IMDZ ), an immunotherapy company focused on next-generation therapies in oncology, today announced that it will report [...]
Inovalon Announces First Quarter 2018 Earnings Conference Call
25/04/2018
BOWIE, Md., April 25, 2018 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV ), a leading technology company providing advanced, cloud-based platforms empowering a data-driven transformation from volume-based to value-based [...]
Report from the Annual General Meeting of Immunicum AB (publ) on April 25, 2018
25/04/2018
Press Release 25 April 2018 Report from the Annual General Meeting of Immunicum AB (publ) on April 25, 2018 Immunicum AB (publ; IMMU.ST) today reported that the annual general meeting (the "AGM") of April 25, 2018 [...]
Misonix to Report Fiscal 2018 Third Quarter Financial Results, Host Conference Call and Webcast on May 7
25/04/2018
FARMINGDALE, N.Y., April 25, 2018 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON ) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, [...]
Changes to the Financial Calendar
25/04/2018
AS Olainfarm hereby informs, that due to changes of business days in Latvia, company’s audited report for 2017 will be published on April 27th, instead of previously announced April 30th. Information prepared by: Salvis [...]
Aptose Announces Appointment of Caroline M. Loewy to Board of Directors
25/04/2018
SAN DIEGO and TORONTO, April 25, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO ) (TSX: APS ), a clinical-stage company developing highly differentiated therapeutics targeting the underlying mechanisms [...]
Cohera Medical Inc.® Awarded Patent on its Biodegradable Sealant Technology
25/04/2018
RALEIGH, N.C., April 25, 2018 (GLOBE NEWSWIRE) -- Cohera Medical, Inc., a leading innovator and developer of absorbable surgical adhesives and sealants, today announced that the U.S. Patent and Trademark Office (USPTO) [...]
Ceapro Inc. Presents PGX Enabling Technology Case Study at the 12th International Symposium on Supercritical Fluids
25/04/2018
– Ceapro receives issued European Patent for PGX Technology – – Poster presentation on a new PGX-dried chemical complex gum Arabic/CoQ10 – EDMONTON, Alberta, April 25, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO [...]
Nabriva Therapeutics to Participate in Two Investor Conferences in May
25/04/2018
DUBLIN, Ireland and KING OF PRUSSIA, Pa., April 25, 2018 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV ), a clinical stage biopharmaceutical company engaged in the research and development of novel anti- [...]
U.S. FDA Clears Pluristem’s Phase III Study in Treatment of Muscle Injury Following Hip Fracture Surgery
25/04/2018
Multinational study expected to include clinical sites in U.S. Israel and Europe, where study has been awarded an $8.7 million grant from European Horizon 2020 Program HAIFA, Israel, April 25, 2018 (GLOBE NEWSWIRE) -- [...]
Zynerba Pharmaceuticals Announces Twelve Month ZYN002 Data from STAR 2 Study in Patients with Focal Seizures at the 2018 Annual Meeting of the American Academy of Neurology (AAN)
25/04/2018
Continued Improvement in Seizure Control Seen in Adult Refractory Focal Seizure Patients Receiving ZYN002 through 12 Months of Open Label Exposure LOS ANGELES, April 25, 2018 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals [...]
Asterias Announces Clinical Grade Lot Released to Support Dosing of First Subjects in First Clinical Study of AST-VAC2
25/04/2018
-Release of clinical grade lot of AST-VAC2 is key step in Cancer Research UK’s initiation of clinical study in Non-Small Cell Lung Cancer - FREMONT, Calif., April 25, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, [...]
Sharps Compliance Reports Fiscal 2018 Third Quarter Results
25/04/2018
Quarterly revenue of $9 . 4 million increased 10% over the prior year third quarter Unused Medication solutions business increased 111%; represents over 20% of total Company billings Route-based business increased 15% [...]
Avivagen Announces OxC-beta™ Purchase Order with New Customer
25/04/2018
OTTAWA, April 25, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”) is a life sciences corporation focused on developing and commercializing products for livestock, [...]
PCI Biotech: Publication of prospectus summary for transfer of listing to Oslo Børs
25/04/2018
Oslo (Norway), 25 th April 2018 - Reference is made to the stock exchange announcement made on 25 April 2018 regarding PCI Biotech Holding ASA ("PCI Biotech" or the "Company") being approved for listing on Oslo Børs as [...]
Financial calendar 2019
25/04/2018
Read the full announcement in the attached file Attachment 2018_17_Financial_calendar_EN

Pages